October 3, 2022

[FEATURED] Calls For More Patient Input In Medical Device Development and Regulation

It is vital to involve patients in medical device development, regulatory assessments, and post-marketing activities. The European Patients’ Academy on Therapeutic Innovation (EUPATI) has explained why and what it is doing to drive progress.

Do you like it?0
September 25, 2022

[FEATURED] EU MDR: Notified Body Clinical Evidence Expectations Could Spell Trouble for Manufacturers

Detailed guidance documents aim to provide clarity on what constitutes “sufficient” clinical evidence under the ­new EU Medical Device Regulation. But a void remains between the MDR itself and what notified bodies expect, senior regulatory consultant Søren Underbjerg attests.

Do you like it?0
September 19, 2022

[FEATURED] EU MDR Implementation Group Reinforces Historic Clinical Evidence Guidance Document Value

Determining how to provide adequate clinical evidence for CE marking under the EU’s Medical Device Regulation can be a tricky business. But legacy device manufacturers will take comfort knowing they are familiar with some elements of the latest guidance.

Do you like it?0
September 13, 2022

[FEATURED] Much More Is Needed, Industry Says To EU’s 19-Point Regulatory Action Plan

The new EU Medical Device and IVD Regulations are reaching a critical tipping point. The 19-point plan just released is not going to cut it, medtech players fear. Is this really the lifeline needed for the medtech industry?

Do you like it?0
September 5, 2022

[FEATURED] Why EU Regulations Are Changing The Face Of Innovation And May Be Unsustainable

The EU must keep its medtech regulation under review as rapidly changing technology and external market factors may be challenging the operability of some aspects of the new medtech regulations, especially for less mature businesses and SMEs. Legal medtech expert, Shuna Mason, of CMS explains why.

Do you like it?0

Named the #1 Regulatory Services Company 2022 by Life Sciences Review

X